These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33796917)

  • 1. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD34
    van Eck van der Sluijs J; van Ens D; Brummelman J; Heister D; Sareen A; Truijen L; van Ingen Schenau DS; Heemskerk MHM; Griffioen M; Kester MGD; Schaap NPM; Jansen JH; van der Waart AB; Dolstra H; Hobo W
    Cell Mol Life Sci; 2023 Sep; 80(10):298. PubMed ID: 37728691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses
    Thordardottir S; Schaap N; Louer E; Kester MG; Falkenburg JH; Jansen J; Radstake TR; Hobo W; Dolstra H
    Oncoimmunology; 2017; 6(3):e1285991. PubMed ID: 28405517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
    Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
    J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
    Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
    Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors.
    Chen W; Antonenko S; Sederstrom JM; Liang X; Chan AS; Kanzler H; Blom B; Blazar BR; Liu YJ
    Blood; 2004 Apr; 103(7):2547-53. PubMed ID: 14670916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.
    Balan S; Ollion V; Colletti N; Chelbi R; Montanana-Sanchis F; Liu H; Vu Manh TP; Sanchez C; Savoret J; Perrot I; Doffin AC; Fossum E; Bechlian D; Chabannon C; Bogen B; Asselin-Paturel C; Shaw M; Soos T; Caux C; Valladeau-Guilemond J; Dalod M
    J Immunol; 2014 Aug; 193(4):1622-35. PubMed ID: 25009205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
    Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
    J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells.
    Thordardottir S; Hangalapura BN; Hutten T; Cossu M; Spanholtz J; Schaap N; Radstake TR; van der Voort R; Dolstra H
    Stem Cells Dev; 2014 May; 23(9):955-67. PubMed ID: 24325394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors.
    Ohishi K; Katayama N; Mitani H; Araki H; Masuya M; Suzuki H; Hoshino N; Miyashita H; Nishii K; Kageyama S; Minami N; Shiku H
    Int J Hematol; 2001 Oct; 74(3):287-96. PubMed ID: 11721965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
    Siena S; Di Nicola M; Bregni M; Mortarini R; Anichini A; Lombardi L; Ravagnani F; Parmiani G; Gianni AM
    Exp Hematol; 1995 Dec; 23(14):1463-71. PubMed ID: 8542932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells.
    Canque B; Camus S; Dalloul A; Kahn E; Yagello M; Dezutter-Dambuyant C; Schmitt D; Schmitt C; Gluckman JC
    Blood; 2000 Dec; 96(12):3748-56. PubMed ID: 11090056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
    Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
    J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.